Price T Rowe Associates Inc Codexis, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 20,794 shares of CDXS stock, worth $67,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,794
Previous 20,794
-0.0%
Holding current value
$67,164
Previous $73,000
10.96%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CDXS
# of Institutions
126Shares Held
48.2MCall Options Held
33.7KPut Options Held
20.2K-
Black Rock Inc. New York, NY6.79MShares$21.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$13.2 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.63MShares$11.7 Million0.75% of portfolio
-
Opaleye Management Inc. Boston, MA3.46MShares$11.2 Million2.74% of portfolio
-
Baillie Gifford & CO2.71MShares$8.75 Million0.01% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $212M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...